Xihuang pill induces pyroptosis and inhibits progression of breast cancer cells via activating the cAMP/PKA signalling pathway.

Xihuang pill (XHP), a traditional Chinese medicine, has been shown to be effective for breast cancer (BC) therapy in clinical trials. However, the molecular mechanism of XHP in BC remains unclear. The molecular mechanism of XHP in BC was investigated in vivo by generating murine mammary carcinoma 4T1 cell xenografts. Enzyme-linked immunosorbent assay (ELISA) and reverse transcription quantitative real-time polymerase chain reaction (RT-qPCR) were used to detect pyroptosis-related indicators. Transcriptome sequencing was used to identify potential targets of XHP. Cell counting kit-8 (CCK-8), EdU, cell wound-healing, and transwell assays were performed to investigate the role of XHP in BC cells. Western blotting was performed to identify proteins related to the cAMP/PKA signalling pathway. XHP inhibited the growth of BC and induced pyroptosis. Western blotting confirmed the significant association between XHP and the cAMP/PKA signalling pathway revealed by Kyoto Encyclopedia of Genes and Genomes pathway analysis. XHP inhibited BC cell proliferation, migration, and invasion, and induced pyroptosis. Inhibiting the cAMP/PKA signalling pathway reversed the anti-cancer activity of XHP. XHP inhibits proliferation, migration, and invasion, and induces pyroptosis of BC cells via activating the cAMP/PKA signalling pathway.